1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Australian Oilseeds Holdings received a Nasdaq notice that its share price has been below the $1.00 minimum for 30 consecutive business days, with until November 24, 2025 to regain compliance. For the quarter ended March 31, 2025, sales revenue rose 49.8% to A$9.4 million, but the company swung to a net loss of A$0.6 million from net income of A$41 thousand a year earlier.
Nasdaq bid price notice received May 27, 2025; 180 calendar days, to November 24, 2025, to regain compliance with the $1.00 minimum
Sales revenue up 49.8% to A$9.4 million; retail oil revenue up 69.4% to A$4.7 million
Net loss of A$0.6 million versus net income of A$41 thousand in the prior-year quarter
Effective May 22, 2025, JSKS Enterprises, controlled by CEO Gary Seaton, converted about A$5 million of loans into 4,452,479 shares at $0.7241 per share
On May 29, 2025, Carlyle subsidiaries entered a Third Amended and Restated Credit Agreement that keeps the $1.0 billion unsecured revolving credit facility at the same size, with no amounts currently outstanding, and extends its maturity from April 29, 2027 to May 29, 2030. The same day, shareholders elected all eight director nominees, ratified Ernst & Young LLP as auditor, and voted on a non-binding say-on-pay proposal in which FOR votes outnumbered AGAINST votes.
Revolver size stays at $1.0 billion with nothing drawn; the company can increase it or add term loans by up to $250.0 million in aggregate.
Maturity extended from April 29, 2027 to May 29, 2030; interest is based on SOFR plus a 0.10% adjustment and a margin of up to 1.50%.
Covenants require management fee earning assets of at least $156.9 billion and a total leverage ratio below 4.0 to 1.0, tested quarterly.
Say-on-pay: 206,466,540 FOR and 87,041,794 AGAINST; all eight directors were elected at the May 29, 2025 annual meeting.
Oyster Enterprises II Acquisition Corp, a blank-check SPAC, completed its initial public offering on May 23, 2025, selling 25,300,000 units at $10.00 each for $253,000,000 in gross proceeds, including the full over-allotment option. The full $253,000,000 was placed in a U.S.-based trust account, and an audited balance sheet as of May 23, 2025 was filed as Exhibit 99.1.
IPO closed May 23, 2025: 25,300,000 units at $10.00 per unit, including 3,300,000 units from the full over-allotment option
Private placement of 708,000 units to the sponsor and BTIG, LLC for $7,080,000 in gross proceeds
$253,000,000 placed in trust account with Continental Stock Transfer & Trust Company as trustee
Company has not selected a business combination target and has 24 months from the IPO closing to complete one
Equifax said Todd Horvath, head of its U.S. Information Solutions unit, will leave the company effective June 1, 2025, and that CEO Mark Begor will lead USIS until a successor is found. The filing also discloses a separation package including a $2.9 million lump-sum severance payment and about $3.2 million in cash for unvested new-hire equity, which is a cost to the company.
Todd Horvath departs as EVP and President, U.S. Information Solutions, effective June 1, 2025
CEO Mark Begor will lead USIS while the company searches for a successor
Lump-sum severance of $2.9 million, about two years of annual cash compensation before taxes and withholdings
About $3.2 million in cash for the unvested portion of his new-hire "make whole" equity award; prorated 2025 incentive payable in Q1 2026
AAON and two subsidiaries signed a Fifth Amendment to their loan agreement with a group of lenders led by BOKF, NA dba Bank of Oklahoma. The revolving commitment rises from $230 million to $500 million, the existing term loan will be paid off, and the maturity extends to May 27, 2030. The larger credit line gives the company more borrowing capacity, and the filing does not state the amount drawn.
Revolving commitments increase from $230 million to $500 million, effective with the May 29, 2025 amendment
Existing term loan to be paid in full from revolving loan proceeds
Revolving commitment termination date extended from May 27, 2027 to May 27, 2030
Bank of America and Associated Bank join as new lenders; BOKF, NA dba Bank of Oklahoma is administrative agent
Humana entered a $5.0 billion unsecured revolving credit agreement on May 30, 2025, which increases its existing 5-year commitments from $2.642 billion and replaces a 364-day $2.1 billion facility. As of May 30, 2025, the company had no borrowings outstanding and about $4.98 billion of remaining borrowing capacity, so the change adds liquidity without new debt drawn. The filing is administrative in nature, and the agreement includes a maximum debt to capitalization covenant that shareholders may want to note.
New facility totals $5.0 billion, unsecured, and permits up to $1.0 billion of incremental commitments
Increases existing 5-year commitments from $2.642 billion and replaces a 364-day $2.1 billion agreement dated May 31, 2024
As of May 30, 2025, no borrowings outstanding and about $14.7 million of undrawn letters of credit, leaving about $4.98 billion available
Full agreement to be filed as an exhibit to the Form 10-Q for the six months ending June 30, 2025
Dutch Bros subsidiaries entered into an amended and restated $650 million senior secured credit facility with JPMorgan Chase Bank, N.A. as administrative agent, effective May 29, 2025, which replaces the 2022 facility. The new facility expires May 29, 2030, and on the effective date the borrowers drew the full $150 million term loan and $50 million in revolving loans. The facility includes leverage and coverage covenants and restrictions on additional debt, liens, acquisitions, and restricted payments, which shareholders may want to track.
Replaces the 2022 Credit Facility, which was repaid and terminated, with a facility expiring May 29, 2030.
Provides up to $650 million in credit: a $500 million revolving facility and a term loan of up to $150 million.
On May 29, 2025, the Loan Parties drew the full $150 million term loan and $50 million in revolving loans.
Quarterly commitment fee of 0.20% to 0.45% on unused revolver capacity; accordion option of up to the greater of $230 million or 80% of EBITDAR.
Neurocrine Biosciences said Sanjay Keswani, M.D. will succeed Eiry W. Roberts, M.D. as Chief Medical Officer effective June 2, 2025. Dr. Roberts, who has held the role for seven years, will stay on as Strategic Advisor to the CEO through December 31, 2025 under an amended employment agreement with a $731,400 base salary.
Sanjay Keswani, M.D. succeeds Eiry W. Roberts, M.D. as Chief Medical Officer effective June 2, 2025
Dr. Roberts becomes Strategic Advisor to the CEO through December 31, 2025, with a $731,400 annual base salary
Dr. Roberts's target bonus is 60% of base pay for calendar year 2025; severance and outstanding equity awards carry over
GATX agreed on May 29, 2025 to acquire about 105,000 railcars from Wells Fargo for $4.4 billion through a new joint venture with Brookfield Infrastructure, in which GATX holds 30% and Brookfield 70%. Closing is expected in the first quarter of 2026 or sooner, subject to regulatory approvals, and GATX expects the deal to be modestly accretive to earnings per share in the first full year after closing.
Purchase price is $4.4 billion for about 105,000 railcars; GATX's initial equity contribution is about $400 million
Joint venture financing includes a $3.2 billion 5-year unsecured term loan and a $250 million unsecured revolving credit facility
Termination fee of $275 million is payable by the JV in certain circumstances; GATX would bear 50% if payable
Outside Date is June 1, 2026, subject to a three-month extension in certain circumstances
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.